PRA8 COSTS AND BENEFITS ASSOCIATED WITH INITIATION OF FLUTICASONE VERSUS MONTELUKAST AS CONTROLLER THERAPY IN A MEDICAID ASTHMATIC POPULATION
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60982-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)60982-5/fulltext
Section Title :
Section Order :
170
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60982-5&doi=10.1016/S1098-3015(10)60982-5